Disruption is a pressing problem in the pharmaceutical world; patient health depends on clinical trial organisers avoiding it ...

The FDA announced new provisions that require sponsors to submit Diversity Action Plans. But what does that mean for the ...

The FDA mandate to increase diversity in clinical trials fails to address critical issues in treatment for Black women, ...

AbbVie, a global, research-driven biopharmaceutical company, organized a visit to its R&D facilities—the AbbVie Cambridge ...

The rising prevalence of urticaria is fueling market growth, with increased allergic responses and lifestyle shifts playing key roles. Advances in biologic treatments and a strong development pipeline ...

Europe has been falling behind on clinical trials over the past decade as pharmaceutical companies shift their focus to the ...

BioDuro-Sundia opens new kilogram laboratory at Shanghai to speed development from discovery to preclincal and clinical ...

The global pediatric clinical trial market is poised for significant growth at a CAGR of 5.9% from 2024 to 2034. The global market size is projected to reach USD 17,918.1 million in 2024. By 2034, the ...

As the pharmaceutical industry rapidly transforms, companies seeking to achieve and hold the leading positions on the market ...

Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America (“RCA”), a leading ...